Abrdn Healthcare Investors (NYSE:HQH – Get Free Report) was the target of a significant drop in short interest during the month of October. As of October 15th, there was short interest totalling 67,000 shares, a drop of 37.3% from the September 30th total of 106,900 shares. Based on an average trading volume of 140,300 shares, the short-interest ratio is currently 0.5 days.
Institutional Investors Weigh In On Abrdn Healthcare Investors
Several institutional investors have recently bought and sold shares of HQH. Northwest Investment Counselors LLC acquired a new position in shares of Abrdn Healthcare Investors during the 3rd quarter valued at $57,000. EverSource Wealth Advisors LLC acquired a new position in shares of Abrdn Healthcare Investors during the second quarter worth about $93,000. Rothschild Investment LLC purchased a new stake in shares of Abrdn Healthcare Investors in the second quarter worth about $101,000. Teamwork Financial Advisors LLC acquired a new stake in shares of Abrdn Healthcare Investors in the third quarter valued at about $201,000. Finally, Truist Financial Corp raised its holdings in shares of Abrdn Healthcare Investors by 11.9% during the 2nd quarter. Truist Financial Corp now owns 12,730 shares of the financial services provider’s stock valued at $222,000 after buying an additional 1,355 shares during the period. 32.60% of the stock is currently owned by hedge funds and other institutional investors.
Abrdn Healthcare Investors Price Performance
Abrdn Healthcare Investors stock traded up $0.11 during midday trading on Tuesday, reaching $18.34. The stock had a trading volume of 87,634 shares, compared to its average volume of 156,590. The stock’s 50-day simple moving average is $18.70 and its 200 day simple moving average is $17.86. Abrdn Healthcare Investors has a twelve month low of $14.37 and a twelve month high of $19.79.
Abrdn Healthcare Investors Announces Dividend
About Abrdn Healthcare Investors
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Recommended Stories
- Five stocks we like better than Abrdn Healthcare Investors
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Is McDonald’s Stock a Smart Buy After Sell-Off and Earnings?
- 3 Warren Buffett Stocks to Buy Now
- QuantumScape: Solid State EV Batteries Nearing Commercialization
- Differences Between Momentum Investing and Long Term Investing
- MicroStrategy: Is This Bitcoin-Powered Stock a Buy or a Gamble?
Receive News & Ratings for Abrdn Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.